Cirrhotic Ascites
Authors:
- 1 October 1986
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 105 (4) , 573-585
Abstract
Cirrhotic ascites occurs via both overflow and underfill mechanisms. Intrahepatic hypertension activates a hepatic baroreceptor reflex that enhances renal sodium absorption; plasma volume is expanded. As cirrhosis progresses, the hepatoportal Starling forces become sufficiently disturbed to sequester this "overflow" in the peritoneal cavity, which results in ascites formation. "Underfill" of the vascular system occurs and eventually dominates the clinical picture. Finally, intrahepatic hypertension also activates the renin-angiotensin system, which causes renal vasoconstriction; the increase in renal prostaglandin synthesis maintains renal blood flow. Although cirrhotic ascites is traditionally classified as a transudate, the serum-ascites albumin gradient may be a better indicator of ascites secondary to portal hypertension than other causes. General management of patients with cirrhotic ascites includes severe restriction of dietary sodium intake and bed rest; diuretics are added if spontaneous diuresis does not occur after 3 to 4 days.Keywords
This publication has 91 references indexed in Scilit:
- The Effect of Large Volume Paracentesis on Plasma Volume—A Cause of Hypovolemia?Hepatology, 1985
- SulindacJAMA, 1982
- A Comparison of Acute Reversible Pre- and Postsinusoidal Portal Hypertension on Salt and Water Retention in the DogHepatology, 1982
- Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver diseaseHepatology, 1981
- Physiologic Considerations in the Medical Management of AscitesArchives of internal medicine (1960), 1980
- Characteristics of ascitic fluid in the alcoholic cirrhoticDigestive Diseases and Sciences, 1979
- Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascitesDigestive Diseases and Sciences, 1978
- Metolazone and spironolactone in cirrhosis and the nephrotic syndromeClinical Pharmacology & Therapeutics, 1977
- Prognostic value of spontaneous hyponatremia in cirrhosis with ascitesDigestive Diseases and Sciences, 1976
- Diagnostic Probabilities In Patients With Conspicuous AscitesArchives of internal medicine (1960), 1964